View in EDS

ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals.

Saved in:
Bibliographic Details
Title: ENCORE: A randomized, controlled, open-label non-inferiority study comparing eliglustat to imiglucerase in Gaucher disease type 1 patients on enzyme replacement therapy who have reached therapeutic goals.
Authors: Cox, Timothy M.1, Drelichman, Guillermo2, Cravo, Renata3, Balwani, Manisha4, Burrow, Thomas Andrew5, Martins, Ana Maria6, Lukina, Elena7, Rosenbloom, Barry8, Ross, Leorah9, Angell, Jennifer9, Puga, Ana Cristina9
Source: Molecular Genetics & Metabolism. Feb2014, Vol. 111 Issue 2, pS33-S33. 1p.
Database: Academic Search Ultimate
Description
ISSN:10967192
DOI:10.1016/j.ymgme.2013.12.061